GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 1376 - 1400 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▲ Arbitrary Fluorescence Units (AFU)
IgM Patient 3 11 mild
G26295XE
5294
IgM Patient 3 4 mild
G26295XE
4981
IgA Patient 4 12 mild
G26295XE
406
IgG Patient 4 12 mild
G26295XE
115
IgM Patient 4 12 mild
G26295XE
116
IgA Patient 1 10 moderate
G27689OB
434
IgA Patient 1 22 moderate
G27689OB
419
IgA Patient 1 6 moderate
G27689OB
446
IgG Patient 1 10 moderate
G27689OB
27
IgG Patient 1 22 moderate
G27689OB
35
IgG Patient 1 6 moderate
G27689OB
26
IgM Patient 1 10 moderate
G27689OB
53
IgM Patient 1 22 moderate
G27689OB
170
IgM Patient 1 6 moderate
G27689OB
53
IgA Patient 2 15 mild
G27689OB
441
IgA Patient 2 24 mild
G27689OB
470
IgG Patient 2 15 mild
G27689OB
1342
IgG Patient 2 24 mild
G27689OB
1153
IgM Patient 2 15 mild
G27689OB
222
IgM Patient 2 24 mild
G27689OB
224
IgA Patient 2 3 mild
G27689OB
470
IgG Patient 2 3 mild
G27689OB
2008
IgM Patient 2 3 mild
G27689OB
304
IgA Patient 3 -180 mild
G27689OB
251
IgA Patient 3 11 mild
G27689OB
412

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024